BGM Group (NASDAQ:BGM) Sees Unusually-High Trading Volume – What’s Next?

BGM Group Ltd. (NASDAQ:BGM) shares saw an uptick in trading volume on Tuesday . 36,512 shares changed hands during trading, an increase of 11% from the previous session’s volume of 32,839 shares.The stock last traded at $7.87 and had previously closed at $7.70.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of BGM Group in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

BGM Group Trading Down 2.8%

The stock has a fifty day moving average of $9.11 and a 200 day moving average of $9.87.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mariner LLC bought a new stake in shares of BGM Group in the 3rd quarter worth approximately $267,000. Marshall Wace LLP purchased a new stake in BGM Group in the 2nd quarter worth about $218,000. Finally, Geode Capital Management LLC bought a new stake in BGM Group in the 2nd quarter valued at about $412,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.